Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
Johanna Chapin-Bardales, Tanya R. Myers, Julianne Gee, David K. Shay, Paige Marquez, James Baggs, Bicheng Zhang, Charles Licata, Tom T. Shimabukuro
Topics & Concepts
ReactogenicityMedicineVaccinationCoronavirus disease 2019 (COVID-19)ReceiptInternal medicinePediatricsEmergency medicineImmunologyImmunogenicityImmune systemComputer scienceDiseaseWorld Wide WebInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancySARS-CoV-2 detection and testing